Raptor Pharmaceuticals Corp. (RPTP.OB) Looks to Be on the Move as Deal with Roche Takes Hold
When considering development stage biotechnology companies, one needs to be aware. There are companies that may appear to be in the backwaters, but then jump to the fore. This is just the nature of the biotechnology beast. Finding and catching the beast is the trick, and it holds no guarantee of success. Playing the game of finding the beast is a skill, but one that can be very profitable. Raptor Pharmaceuticals Corp., a development stage biopharmaceuticals company, works to develop pre-clinical products through its proprietary delivery platform. The company is currently working with several products in the phase II and…